Epilepsy Research
Volume 31, Issue 3 , Pages 187-198, August 1998

Effects of carbamazepine on hippocampal serotonergic system

  • Motohiro Okada

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Hirosaki University, Hirosaki 036, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 172 395066; fax: +81 172 395067; e-mail: okadamot@cc.hirosaki-u.ac.jp
  • ,
  • Takayuki Hirano

      Affiliations

    • Department of Biochemistry Research, Mianami-Hanamaki National Hospital, Hanamaki 025, Japan
  • ,
  • Kazuhisa Mizuno

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Hirosaki University, Hirosaki 036, Japan
  • ,
  • Yuko Kawata

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Hirosaki University, Hirosaki 036, Japan
  • ,
  • Kazumaru Wada

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Hirosaki University, Hirosaki 036, Japan
  • ,
  • Takuya Murakami

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Hirosaki University, Hirosaki 036, Japan
  • ,
  • Hiroichi Tasaki

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Hirosaki University, Hirosaki 036, Japan
  • ,
  • Sunano Kaneko

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Hirosaki University, Hirosaki 036, Japan

Received 17 October 1997; received in revised form 17 March 1998; accepted 28 March 1998.

Abstract 

To establish the mechanism of action of the antiepileptic and psychotropic effects of carbamazepine (CBZ), its effects on serotonin (5-HT) transmission, metabolism and re-uptake activity in the rat hippocampus were studied. After acute and chronic administrations of 25 mg/kg CBZ, the plasma concentration of CBZ was found to be within the therapeutic range, whereas both acute and chronic administrations of 50 and 100 mg/kg CBZ resulted in a supratherapeutic plasma concentration. Acute administration of the therapeutic dose of CBZ resulted in an increase in the hippocampal extracellular and total level of 5-HT, its metabolite, 5-hydroxydoleacetic acid (5-HIAA) and its precursor, 5-hydroxytryptophan (5-HTP). The acute administration of 50 mg/kg CBZ resulted in an increase in the hippocampal levels of extracellular 5-HT and 5-HIAA as well as in the total levels of 5-HTP, whereas hippocampal levels of extracellular 5-HTP, total 5-HT and 5-HIAA remained unaffected. CBZ at a dose of 100 mg/kg decreased the levels of all of these substances. After chronic administration, 25 mg/kg/day CBZ increased hippocampal total levels of 5-HT, 5-HTP and 5-HIAA, whereas 100 mg/kg/day CBZ decreased all of these total levels. CBZ at a dose of 50 mg/kg/day decreased total levels of 5-HT, however neither total levels of 5-HIAA nor 5-HTP were affected. Both therapeutic and supratherapeutic plasma concentrations of CBZ inhibited 5-HTP accumulation, and did not affect 5-HT re-uptake activity in vitro. These results suggest that a therapeutic concentration of CBZ enhances 5-HT turnover and transmission, whereas a supratherapeutic concentration of CBZ inhibits 5-HT turnover and transmission without affecting 5-HT re-uptake activity. These effects of CBZ on serotonergic systems may be, at least partially, involved in the mechanisms of action of CBZ.

Keywords:  Carbamazepine, Epilepsy, Microdialysis, Serotonin release, Serotonin metabolism

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-1211(98)00025-4

Epilepsy Research
Volume 31, Issue 3 , Pages 187-198, August 1998